Your browser doesn't support javascript.
loading
Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis.
Magremanne, Michèle; Reychler, Hervé.
Affiliation
  • Magremanne M; Consultant, Department of Oral and Maxillofacial Surgery, Cancer Center Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. Electronic address: magremanne.michele@gmail.com.
  • Reychler H; Department Head, Department of Oral and Maxillofacial Surgery, Cancer Center Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
J Oral Maxillofac Surg ; 72(2): 334-7, 2014 Feb.
Article in En | MEDLINE | ID: mdl-23891014
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Pentoxifylline / Tocopherols / Diphosphonates / Bone Density Conservation Agents / Bisphosphonate-Associated Osteonecrosis of the Jaw / Imidazoles / Antioxidants Type of study: Risk_factors_studies Limits: Humans / Male / Middle aged Language: En Journal: J Oral Maxillofac Surg Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoporosis / Pentoxifylline / Tocopherols / Diphosphonates / Bone Density Conservation Agents / Bisphosphonate-Associated Osteonecrosis of the Jaw / Imidazoles / Antioxidants Type of study: Risk_factors_studies Limits: Humans / Male / Middle aged Language: En Journal: J Oral Maxillofac Surg Year: 2014 Document type: Article Country of publication: United States